Zobrazeno 1 - 10
of 27
pro vyhledávání: '"J P, Muratet"'
Autor:
J P Muratet, Raymonde Bouvier, Jean-Léon Lagrange, J.M. Bachaud, Michel Soulié, D Rossi, Vincent Molinié, O Haillot, P PabotduChatelard, D Brune, A Daver, N Berger, A Villers, M. Peneau, Béatrice Fervers, E Fontaine, A F Bertrand, Pierre Richaud, D Prapotnitch, V. Ravery, P. Pommier, A Bataillard
Publikováno v:
Cancer/Radiothérapie. 6:119-126
Contexte. - La Federation nationale des centres de lutte contre le cancer (FNCLCC) et les Centres regionaux de lutte contre le cancer (CRLCC), en collaboration avec des partenaires des secteurs public (CHU, CHG), prive et certaines societes savantes
Autor:
Raymonde Bouvier, V. Ravery, M. Peneau, N Berger, E Fontaine, Jean-Léon Lagrange, D Rossi, Jean-Yves Soret, J.M. Bachaud, D Prapotnitch, A Villers, D Brune, Vincent Molinié, A Daver, B Guilloneau, A Bataillard, Pierre Richaud, Béatrice Fervers, A F Bertrand, J P Muratet, P Pabot du Chatelard, O Haillot, P. Pommier
Publikováno v:
Cancer/Radiothérapie. 5:770-786
Contexte. - La Federation nationale des centres de lutte contre le cancer (FNCLCC) et les Centres regionaux de lutte contre le cancer (CRLCC), en collaboration avec des partenaires des secteurs public (CHU, CHG), prive et certaines societes savantes
Publikováno v:
Clinical Chemistry. 42:258-262
Five monoclonal antibodies (MAbs) directed against antigenic domains on thyroglobulin (Tg) not recognized by most anti-Tg human autoantibodies (aAbs) have been used to develop an improved IRMA for serum Tg with a limit of detection of 0.2 micrograms/
Autor:
P, Pommier, A, Villers, A, Bataillard, D, Brune, B, Fervers, J M, Bachaud, N, Berger, A F, Bertrand, R, Bouvier, A, Daver, E, Fontaine, O, Haillot, J L, Lagrange, V, Molinié, J P, Muratet, P, Pabot du Chatelard, M, Peneau, D, Prapotnitch, V, Ravery, P, Richaud, D, Rossi, M, Soulié
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 6(2)
The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals
Autor:
P, Pommier, A, Villers, A, Bataillard, D, Brune, B, Fervers, J M, Bachaud, N, Berger, A F, Bertrand, R, Bouvier, A, Daver, E, Fontaine, B, Guilloneau, O, Haillot, J L, Lagrange, V, Molinié, J P, Muratet, P, Pabot du Chatelard, M, Peneau, D, Prapotnitch, V, Ravery, P, Richaud, D, Rossi, J Y, Soret
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 5(6)
The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(9)
The therapeutic outcome after (131)I first ablative treatment in patients operated on for nonmedullary differentiated thyroid carcinoma was compared after both the currently used scanning dose of 111 MBq (131)I and a scanning dose of 37 MBq (131)I.Tw
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(9)
The purpose of this study was to search for predictors of (131)I first ablative treatment efficacy in patients with postsurgical remnants after total thyroidectomy for nonmedullary differentiated thyroid carcinoma with no known metastasis.Thirty-seve
Publikováno v:
Médecine Nucléaire. 37:157
Autor:
P Y, Marquet, A, Daver, R, Sapin, B, Bridgi, J P, Muratet, D J, Hartmann, F, Paolucci, B, Pau
Publikováno v:
Clinical chemistry. 42(2)
Five monoclonal antibodies (MAbs) directed against antigenic domains on thyroglobulin (Tg) not recognized by most anti-Tg human autoantibodies (aAbs) have been used to develop an improved IRMA for serum Tg with a limit of detection of 0.2 micrograms/
Autor:
P Giraud, J P Muratet
Publikováno v:
Clinical Nuclear Medicine. 21:736-737
Eight months after initial I-131 ablative therapy for papillary carcinoma in a 22-year-old woman, a second I-131 treatment was performed and a post-therapeutic study demonstrated increased activity in the upper mediastinum. Mediastinal uptake was not